Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group; Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith M, Sibony P, Plumb K, Wang JK, Werner JS. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, et al. Among authors: auinger p. Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8180-8. doi: 10.1167/iovs.14-14960. Invest Ophthalmol Vis Sci. 2014. PMID: 25370510 Free PMC article. Clinical Trial.
Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group; Auinger P, Durbin M, Feldon S, Garvin M, Kardon R, Keltner J, Kupersmith MJ, Sibony P, Plumb K, Wang JK, Werner JS. OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group, et al. Among authors: auinger p. Invest Ophthalmol Vis Sci. 2014 Nov 4;55(12):8173-9. doi: 10.1167/iovs.14-14961. Invest Ophthalmol Vis Sci. 2014. PMID: 25370513 Free PMC article. Clinical Trial.
The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Wall M, Kupersmith MJ, Thurtell MJ, Moss HE, Moss EA, Auinger P; NORDIC Idiopathic Intracranial Hypertension Study Group. Wall M, et al. Among authors: auinger p. Am J Ophthalmol. 2017 Apr;176:102-107. doi: 10.1016/j.ajo.2017.01.004. Epub 2017 Jan 17. Am J Ophthalmol. 2017. PMID: 28104417 Free PMC article. Clinical Trial.
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N. Banno H, et al. Among authors: auinger p. J Huntingtons Dis. 2017;6(2):149-156. doi: 10.3233/JHD-170246. J Huntingtons Dis. 2017. PMID: 28671136 Free PMC article.
Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.
Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K; NET-PD Investigators. Constantinescu R, et al. Among authors: auinger p. Mov Disord. 2014 Feb;29(2):263-5. doi: 10.1002/mds.25734. Epub 2013 Dec 3. Mov Disord. 2014. PMID: 24323565 Free PMC article. Clinical Trial.
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N. Banno H, et al. Among authors: auinger p. J Huntingtons Dis. 2017;6(4):371. doi: 10.3233/JHD-179002. J Huntingtons Dis. 2017. PMID: 28922164 No abstract available.
154 results